<DOC>
	<DOCNO>NCT01456429</DOCNO>
	<brief_summary>This prospective non-randomized multicenter clinical trial perform endobronchial esophageal ultrasound mediastinal lymph node stag operable resectable cT1-T2-selectedT3 cN1 cM0 NSCLC .</brief_summary>
	<brief_title>Assessment Invasive Mediastinal Staging cN1 Lung Cancer .</brief_title>
	<detailed_description>Provided mediastinal lymph node metastasis proven echoendoscopy , patient subsequently undergo surgical staging . Patients without tissue proof mediastinal nodal disease surgical staging undergo thoracotomy systematic lymph node dissection . Provided mediastinal lymph node metastasis proven echoendoscopy , patient go study protocol assessed/treated accord local clinical practice .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>Patients operable resectable ( suspect ) NSCLC Patients clinical N1 staging base PET/CT Only T1 , T2 , select T3 ( i.e . intraparenchymal tumour &gt; 7cm , chest wall , additional nodule lobe ) allow . Patients enlarge mediastinal lymph node chest CT FDGPET positive mediastinal lymph node Patients central tumour stag T3 T4 . All stage IV patient . Patient unable give inform consent . Patient previously underwent mediastinoscopy . Tracheal upper airway stenosis .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>invasive staging</keyword>
	<keyword>mediastinal lymph node</keyword>
	<keyword>endosonography</keyword>
	<keyword>surgical staging</keyword>
	<keyword>lung cancer</keyword>
</DOC>